Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer
patients with lymph node metastasis should receive after neoadjuvant chemotherapy. For …

Background AKT pathway activation is implicated in endocrine-therapy resistance. Data on
the efficacy and safety of the AKT inhibitor capivasertib, as an addition to fulvestrant therapy, …

Immuno-oncology is a rapidly developing field in medicine. Drug combination therapies
have already been studied in many clinical trials on various tumor types. In recent years, a …

Background This randomised, double-blind study compared PF-05280014 (a trastuzumab
biosimilar) with reference trastuzumab (Herceptin®) sourced from the European Union (…

Background The spectrum of BRCA1 and BRCA2 mutations in Slavic countries is characterized
by a high prevalence of founder alleles. Methods We analyzed a large data set of …

We report the first application of compression optical coherence elastography (C-OCE) to
evaluate both linear and nonlinear elastic properties of lymph nodes (LNs) for assessing their …

As part of the up-to-date multidisciplinary treatment of breast cancer, organ specialized onco-surgery,
breast surgery has evolved in many ways over the past decades. The most …

Simple Summary Multiple technological solutions are being explored to be used in the
intraoperative assessment of resection margins in breast cancer and detection of the residual …

Aim: Neo-adjuvant chemotherapy is a common approach for the complex treatment of breast
cancer (BC) and paclitaxel (PTX) is frequently included in the therapeutic regimen. However…

e13537 Background: NanoBB-1-Dox is a novel drug candidate for systemic chemotherapy of
glioblastoma multiforme (GBM). It is a nanoparticle-based formulation of doxorubicin, which …